Home
Reels
Gruppi
Pagine
Mostra tutto
Gruppi Pagine Events Blogs Funding
Registrati Iscriviti
Night Mode
Biosimilar Uptake: What Drives Adoption of Herceptin Alternatives?
The availability of biosimilars doesn't automatically translate to adoption. Despite regulatory approval and price advantages, uptake of Herceptin biosimilars varies widely across markets, reflecting complex interactions between payer policies, clinician preferences, patient awareness, and healthcare system structures. Understanding what drives adoption is essential for manufacturers,...
0 Commenti ·0 condivisioni ·26 Views ·0 Anteprima
Effettua l'accesso per mettere mi piace, condividere e commentare!